Wikidata |

Wikidata

Matches in Wikidata for { <http://www.wikidata.org/entity/Q58792074> ?p ?o ?g. }

Showing items 1 to 100 of ±158 with 100 items per page.

Q58792074 description "im September 2018 veröffentlichter wissenschaftlicher Artikel" @default.
Q58792074 description "wetenschappelijk artikel" @default.
Q58792074 description "наукова стаття, опублікована у вересні 2018" @default.
Q58792074 name "Addition of Vincristine and Irinotecan to Vincristine, Dactinomycin, and Cyclophosphamide Does Not Improve Outcome for Intermediate-Risk Rhabdomyosarcoma: A Report From the Children's Oncology Group" @default.
Q58792074 name "Addition of Vincristine and Irinotecan to Vincristine, Dactinomycin, and Cyclophosphamide Does Not Improve Outcome for Intermediate-Risk Rhabdomyosarcoma: A Report From the Children's Oncology Group" @default.
Q58792074 type Item @default.
Q58792074 label "Addition of Vincristine and Irinotecan to Vincristine, Dactinomycin, and Cyclophosphamide Does Not Improve Outcome for Intermediate-Risk Rhabdomyosarcoma: A Report From the Children's Oncology Group" @default.
Q58792074 label "Addition of Vincristine and Irinotecan to Vincristine, Dactinomycin, and Cyclophosphamide Does Not Improve Outcome for Intermediate-Risk Rhabdomyosarcoma: A Report From the Children's Oncology Group" @default.
Q58792074 prefLabel "Addition of Vincristine and Irinotecan to Vincristine, Dactinomycin, and Cyclophosphamide Does Not Improve Outcome for Intermediate-Risk Rhabdomyosarcoma: A Report From the Children's Oncology Group" @default.
Q58792074 prefLabel "Addition of Vincristine and Irinotecan to Vincristine, Dactinomycin, and Cyclophosphamide Does Not Improve Outcome for Intermediate-Risk Rhabdomyosarcoma: A Report From the Children's Oncology Group" @default.
Q58792074 P1433 Q58792074-BCF47EAB-26D0-4811-A041-4130DF6555A0 @default.
Q58792074 P1476 Q58792074-FF096D29-FCBA-46C5-B246-6A82CDDF2587 @default.
Q58792074 P2093 Q58792074-088D4F0D-06A7-4013-88F8-B22F353C935B @default.
Q58792074 P2093 Q58792074-1B6E7BA7-B069-46A9-824E-58A0A3F7179A @default.
Q58792074 P2093 Q58792074-26816B02-B8C3-455A-822E-A1B32A20DC31 @default.
Q58792074 P2093 Q58792074-2A95CDB2-87BF-4632-9F25-4C0890182CC8 @default.
Q58792074 P2093 Q58792074-34679EC4-3AB8-496D-A65D-C8FC849491F2 @default.
Q58792074 P2093 Q58792074-49A11B48-63BB-4A9F-BBD9-3C6C4FBF5C4F @default.
Q58792074 P2093 Q58792074-4C6491F7-E3C2-41C7-8CD1-E5701768748B @default.
Q58792074 P2093 Q58792074-4DE523A4-F802-4B08-8DE9-EA237F6AD21B @default.
Q58792074 P2093 Q58792074-52597038-248F-47EA-A319-ECD898262B89 @default.
Q58792074 P2093 Q58792074-5FDD8C85-2EC2-4EF0-B0D2-3BED9395B360 @default.
Q58792074 P2093 Q58792074-60BE2F40-4281-4A32-A1BF-B5113A40D456 @default.
Q58792074 P2093 Q58792074-89206CFA-6ADA-41D8-A05D-D30F1F5DF4B3 @default.
Q58792074 P2093 Q58792074-8CE5DE64-0B15-4875-B3C5-3EAC482B79E2 @default.
Q58792074 P2093 Q58792074-8EB5568A-7459-402F-BFD1-3E26A42E2859 @default.
Q58792074 P2093 Q58792074-ABA6F6A0-EB24-4031-BE1F-14D5A52D3D65 @default.
Q58792074 P2093 Q58792074-DF8F98C0-D9AE-4634-905B-370941EDBE3D @default.
Q58792074 P2093 Q58792074-F3EDBA13-74BB-45D1-80D6-318D6AA7E672 @default.
Q58792074 P2860 Q58792074-00A2FBE5-C520-4A91-B134-6132CC86FF44 @default.
Q58792074 P2860 Q58792074-0F78F804-3537-4067-9F7B-4BE69A22970D @default.
Q58792074 P2860 Q58792074-195114D5-5683-48F2-9E08-23CF81B044FC @default.
Q58792074 P2860 Q58792074-21CFA817-4100-4143-B2C7-861582B52883 @default.
Q58792074 P2860 Q58792074-35726624-8C53-4FF3-BED4-0CCEE0F88EAA @default.
Q58792074 P2860 Q58792074-366852F6-2AB8-4F1C-9463-CD5D7767273C @default.
Q58792074 P2860 Q58792074-36A083B7-7577-4082-A82A-A1C401C4C508 @default.
Q58792074 P2860 Q58792074-412E473E-FF9C-4043-8956-69DE35344DB3 @default.
Q58792074 P2860 Q58792074-4F384084-067A-42CA-9D25-9D4A5BCACFD9 @default.
Q58792074 P2860 Q58792074-78258C16-6A18-46EA-A88F-E554F3684C54 @default.
Q58792074 P2860 Q58792074-783DB547-7951-41EE-8C23-081EEA990CBE @default.
Q58792074 P2860 Q58792074-7851F50A-41A5-4189-A913-930C22B2E9AC @default.
Q58792074 P2860 Q58792074-79C58BE6-1C4E-43ED-A2B4-C80623377D50 @default.
Q58792074 P2860 Q58792074-815ED9D1-55DA-4A18-8AA9-D667E3184057 @default.
Q58792074 P2860 Q58792074-831E172B-9B32-41D0-9FEF-00E2C553E0C6 @default.
Q58792074 P2860 Q58792074-8CFBCED0-2927-4D4A-89AB-94C38868EF97 @default.
Q58792074 P2860 Q58792074-91DFE78D-6989-4D6C-A641-7AE3E2FC5096 @default.
Q58792074 P2860 Q58792074-92C6DE61-CB6A-4FBA-B111-949452FC85E8 @default.
Q58792074 P2860 Q58792074-941EFEB7-2747-40B0-8A41-C684A24B1EB5 @default.
Q58792074 P2860 Q58792074-944AFB12-7470-42EE-8741-C2E467DA57D0 @default.
Q58792074 P2860 Q58792074-A2F32961-30F9-49B8-8B51-C946A75B3BE1 @default.
Q58792074 P2860 Q58792074-A63CADA3-FCAD-4F13-826F-A552857FACB3 @default.
Q58792074 P2860 Q58792074-A99030BE-CE5F-4B01-8C7B-59A9DFD85350 @default.
Q58792074 P2860 Q58792074-ACE93E6E-5176-470B-93B4-A9A92F30F327 @default.
Q58792074 P2860 Q58792074-AE19B2EA-DB05-4C1F-BDAA-979C84679C15 @default.
Q58792074 P2860 Q58792074-B1198F1C-2195-4A89-B46C-750B26BD3F29 @default.
Q58792074 P2860 Q58792074-B80A93FC-2F57-4530-B4FE-3DEC53CDCADC @default.
Q58792074 P2860 Q58792074-C9732703-7CD4-418C-B129-892E33FF385D @default.
Q58792074 P2860 Q58792074-CCDDE117-A131-40F1-80A3-5E336FCCFE6C @default.
Q58792074 P2860 Q58792074-DCD44BF1-C07A-4595-B8B4-032691468E99 @default.
Q58792074 P2860 Q58792074-E92234CF-3DDF-41DC-AFA0-9E14C792C5CA @default.
Q58792074 P2860 Q58792074-EC570C9E-9514-4FDC-8672-A0D10364A73D @default.
Q58792074 P2860 Q58792074-FA23208D-20F4-4E5B-A7E4-39D33727451F @default.
Q58792074 P2860 Q58792074-FC60F31F-8B43-4C5F-97EB-1CAC3808E9FD @default.
Q58792074 P304 Q58792074-5B171F24-A108-4147-867F-37BE80B9A103 @default.
Q58792074 P31 Q58792074-2C8E77B0-E637-434F-A84B-7A3F6B5D661E @default.
Q58792074 P356 Q58792074-B0B720CF-0B46-4EEE-8D72-85DAB42E5361 @default.
Q58792074 P407 Q58792074-3E18FEDF-732F-41DE-BDF0-8D1541C45B6F @default.
Q58792074 P433 Q58792074-62DFE37B-3D08-4723-A84D-2F2F85C4AE99 @default.
Q58792074 P478 Q58792074-62680375-477D-4D6A-A50A-0299FECA1015 @default.
Q58792074 P50 Q58792074-0711ECCA-5AA1-4850-BFD1-E103F46E2B2F @default.
Q58792074 P50 Q58792074-0CDCB790-32BE-47E1-8E4B-9929CC229961 @default.
Q58792074 P50 Q58792074-0D160204-83C9-4A3C-A1E7-F90C2213DBE3 @default.
Q58792074 P50 Q58792074-2218A0D5-4582-459C-B1D5-F8BA88FCABB8 @default.
Q58792074 P50 Q58792074-6C2A8E81-9FCC-496C-BD0F-05FD8FA44CF9 @default.
Q58792074 P50 Q58792074-E3DB594B-73A9-407B-9A28-72720257282A @default.
Q58792074 P50 Q58792074-F3731F19-5991-4200-8601-57ED6AB1E27D @default.
Q58792074 P577 Q58792074-063B9960-5F7E-44A3-BFB5-B2B4E4240887 @default.
Q58792074 P698 Q58792074-295A868E-1869-4F9B-80E8-04E851759FF6 @default.
Q58792074 P921 Q58792074-9B17117E-30E6-4F30-A14D-117F15A6C6C8 @default.
Q58792074 P921 Q58792074-C3B19008-3E81-4C07-8911-D9BB879543E7 @default.
Q58792074 P921 Q58792074-D15ABF2F-5A87-46DD-A52B-3BB0E27F1302 @default.
Q58792074 P921 Q58792074-E5916297-9864-4765-89C2-220F8FE45BE0 @default.
Q58792074 P932 Q58792074-D9B055F1-120C-415F-80E1-D051CAADB6D4 @default.
Q58792074 P356 JCO.2018.77.9694 @default.
Q58792074 P698 30091945 @default.
Q58792074 P1433 Q400292 @default.
Q58792074 P1476 "Addition of Vincristine and Irinotecan to Vincristine, Dactinomycin, and Cyclophosphamide Does Not Improve Outcome for Intermediate-Risk Rhabdomyosarcoma: A Report From the Children's Oncology Group" @default.
Q58792074 P2093 "Carol D Morris" @default.
Q58792074 P2093 "Carola A S Arndt" @default.
Q58792074 P2093 "David A Rodeberg" @default.
Q58792074 P2093 "David M Parham" @default.
Q58792074 P2093 "Erin R Rudzinski" @default.
Q58792074 P2093 "Geoff McCowage" @default.
Q58792074 P2093 "Jeannine S McCune" @default.
Q58792074 P2093 "Jing Tian" @default.
Q58792074 P2093 "Leo Mascarenhas" @default.
Q58792074 P2093 "Lisa A Teot" @default.
Q58792074 P2093 "Lisa Bomgaars" @default.
Q58792074 P2093 "Lynn Million" @default.
Q58792074 P2093 "Sarah S Donaldson" @default.